{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T06:50:33Z","timestamp":1764053433751},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1097\/txd.0000000000000577","type":"journal-article","created":{"date-parts":[[2016,2,18]],"date-time":"2016-02-18T14:03:07Z","timestamp":1455804187000},"page":"e66","source":"Crossref","is-referenced-by-count":2,"title":["Lowered Immune Cell Function in Liver Recipients Recovered From Posttransplant Lymphoproliferative Disease Who Developed Graft Tolerance"],"prefix":"10.1097","volume":"2","author":[{"given":"Patrick Ho Yu","family":"Chung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"See Ching","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwong Leung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuk Sing","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janette Siu Yin","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung Mau","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-1-20210126","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1034\/j.1399-3062.2001.003002070.x","article-title":"Identifying the patient at risk for post-transplant lymphoproliferative disorder.","volume":"3","author":"Cockfield","year":"2001","journal-title":"Transpl Infect Dis"},{"key":"R2-1-20210126","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/01.TP.0000057244.03192.BD","article-title":"Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment.","volume":"75","author":"Guthery","year":"2003","journal-title":"Transplantation"},{"key":"R3-1-20210126","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1136\/jclinpath-2012-201139","article-title":"Post-transplant lymphoproliferative disorders in liver transplant recipients: a clinicopathological study.","volume":"66","author":"Lo","year":"2013","journal-title":"J Clin Pathol"},{"key":"R4-1-20210126","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00000658-200210000-00005","article-title":"Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience.","volume":"236","author":"Jain","year":"2002","journal-title":"Ann Surg"},{"key":"R5-1-20210126","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1097\/00007890-199711270-00011","article-title":"Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus.","volume":"64","author":"Sokal","year":"1997","journal-title":"Transplantation"},{"key":"R6-1-20210126","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/00007890-199608150-00012","article-title":"Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression.","volume":"62","author":"Newell","year":"1996","journal-title":"Transplantation"},{"key":"R7-1-20210126","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1034\/j.1399-3046.2001.00021.x","article-title":"Primary tacrolimus (FK506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients.","volume":"5","author":"Cacciarelli","year":"2001","journal-title":"Pediatr Transplant"},{"key":"R8-1-20210126","first-page":"94","article-title":"The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.","volume":"70","author":"Younes","year":"2000","journal-title":"Transplantation"},{"key":"R9-1-20210126","first-page":"984","article-title":"Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se Transplantation.","volume":"76","author":"Birkeland","year":"2003","journal-title":""},{"key":"R10-1-20210126","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1399-3046.2004.00129.x","article-title":"Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.","volume":"8","author":"Hurwitz","year":"2004","journal-title":"Pediatr Transplant"},{"key":"R11-1-20210126","first-page":"1157","article-title":"Tolerance: is it worth the risk Transplantation.","volume":"79","author":"Eason","year":"2005","journal-title":""},{"key":"R12-1-20210126","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1034\/j.1399-0012.2003.00013.x","article-title":"Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management.","volume":"17","author":"Kowalski","year":"2003","journal-title":"Clin Transplant"},{"key":"R13-1-20210126","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/lt.21426","article-title":"Immu Know: a new parameter in immune monitoring of pediatric liver transplantation recipients.","volume":"14","author":"Israeli","year":"2008","journal-title":"Liver Transpl"},{"key":"R14-1-20210126","first-page":"106","article-title":"Malignant lymphomas in transplantation patients.","volume":"1","author":"Penn","year":"1969","journal-title":"Transplant Proc"},{"key":"R15-1-20210126","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1200\/JCO.1995.13.4.961","article-title":"Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center.","volume":"13","author":"Leblond","year":"1995","journal-title":"J Clin Oncol"},{"key":"R16-1-20210126","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.critrevonc.2005.03.015","article-title":"Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.","volume":"56","author":"Taylor","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"R17-1-20210126","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/00007890-199502270-00015","article-title":"An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation.","volume":"59","author":"Cox","year":"1995","journal-title":"Transplantation"},{"key":"R18-1-20210126","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJM199012203232502","article-title":"Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients.","volume":"323","author":"Swinnen","year":"1990","journal-title":"N Engl J Med"},{"key":"R19-1-20210126","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.5858\/2007-131-1209-TCSOPL","article-title":"The clinicopathologic spectrum of posttransplantation lymphoproliferative disorders.","volume":"131","author":"Tsao","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"R20-1-20210126","first-page":"83","article-title":"WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview.","volume":"102","author":"Sabattini","year":"2010","journal-title":"Pathologica"},{"key":"R21-1-20210126","doi-asserted-by":"crossref","first-page":"7574","DOI":"10.1200\/JCO.2005.01.0934","article-title":"Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders.","volume":"23","author":"Ghobrial","year":"2005","journal-title":"J Clin Oncol"},{"key":"R22-1-20210126","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1200\/JCO.2008.20.0857","article-title":"Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.","volume":"27","author":"Knight","year":"2009","journal-title":"J Clin Oncol"},{"key":"R23-1-20210126","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1600-6143.2010.03387.x","article-title":"Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder (bigstar).","volume":"11","author":"Reshef","year":"2011","journal-title":"Am J Transplant"},{"key":"R24-1-20210126","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1182\/blood.V86.9.3333.bloodjournal8693333","article-title":"Aggressive treatment for postcardiac transplant lymphoproliferation.","volume":"86","author":"Swinnen","year":"1995","journal-title":"Blood"},{"key":"R25-1-20210126","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/01.tp.0000179639.98338.39","article-title":"Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression.","volume":"80","author":"Caillard","year":"2005","journal-title":"Transplantation"},{"key":"R26-1-20210126","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jim.2013.11.019","article-title":"Comparison of several functional methods to evaluate the immune response on stable kidney transplant patients.","volume":"403","author":"Martinez-Flores","year":"2014","journal-title":"J Immunol Methods"},{"key":"R27-1-20210126","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.humimm.2006.11.005","article-title":"A novel approach to detect donorrecipent immune responses between HLA-identical pairs.","volume":"68","author":"Jin","year":"2007","journal-title":"Hum Immunol"},{"key":"R28-1-20210126","doi-asserted-by":"crossref","first-page":"E351","DOI":"10.1111\/ctr.12134","article-title":"Immune function assay (ImmuKnow) as a predictor of allograft rejection and infection in kidney transplantation.","volume":"27","author":"He","year":"2013","journal-title":"Clin Transplant"},{"key":"R29-1-20210126","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1093\/ndt\/gfr675","article-title":"Trends in immune function assay (ImmuKnow; Cylex) results in the first year post-transplant and relationship to BK virus infection.","volume":"27","author":"Gralla","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R30-1-20210126","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s10157-012-0688-1","article-title":"Use of the ImmuKnow assay to evaluate the effect of alemtuzumab-depleting induction therapy on cell-mediated immune function after renal transplantation.","volume":"17","author":"Zhou","year":"2013","journal-title":"Clin Exp Nephrol"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000000577","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T12:52:48Z","timestamp":1654347168000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01845228-201603000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000000577","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}